Our results of the additive effects of the risk alleles of PNPLA3 and TM6SF2 on NAFLD were consistent with their biological functions, which highlights the possibility to identify high risk individuals by genotyping these two risk factors. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.